Mike Wilkins Suspects Issues at Galectin Therapeutics and InterOil – ValueWalk Premium

Mike Wilkins Suspects Issues at Galectin Therapeutics and InterOil

Mike Wilkins like’s investment fraud.  As the chief investment officer for hedge fund short seller Kingsford Capital, Wilkins makes a profit by spotting fraud and selling the stock, benefiting when the fraud is exposed and the stock moves lower in price.
Mike Wilkins' process
Sounding like an algorithmic trend follower, Wilkins says fraud is identifiable, predictable and a persistent feature in all market environments. At the recent

SORRY!

This content is exclusively for paying members.

If you are subscribed and having an account error please clear cache and cookies if that does not work email support@valuewalk.com or click Chat.


X
Saved Articles
X
TextTExtLInkTextTExtLInk

Here’s a Tip: Read What Professional Investors Read

ValueWalk Premium is for investors looking to improve their investment process AND keep up-to-date on the latest industry trends.

It’s THE resource for value investing and hedge funds. 📈

And with a free three-day trial and $29.99 per month thereafter, it’s a value in its own right.

Sign up now. 👇

CLICK HERE TO TRY IT OUT

 

0